For a non-Chartist the EBR chart looks good to me.
I'm wondering if the 170,000 shares for sale at $1.00 is just a prop to entice weak holders to sell out below a dollar.
Stating the obvious we're now less than 2 months from Q3, in which the submission of the final module for FDA approval is scheduled. That should spark more interest in the Company IMO.
How many cheap shares in EBR will be available from this point is hard to know, but it seems they're drying up.
Charting, page-216
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.015(1.35%) |
Mkt cap ! $346.6M | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.15 | $1.10 | $100.9K | 89.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 9815 | 1 |
View Market Depth
| Last trade - 16.10pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.11 |
Change
0.015 ( 1.81 %) |
||||
| Open | High | Low | Volume | ||
| $1.14 | $1.15 | $1.09 | 76123 | ||
| Last updated 15.57pm 06/06/2024 ? | |||||
| EBR (ASX) Chart |